2015 - 2018 Comprehensive elucidation of MDS (myelodysplastic syndromes) pathogenesis
2014 - 2016 The role of SETBP1 mutation in leukemic transformation
2012 - 2013 骨髄異形成症候群におけるエピジェネティックな発症機構の解明
Show all
Papers (81):
Momoko Nakamura, Kazuhisa Chonabayashi, Megumi Narita, Yasuko Matsumura, Misato Nishikawa, Yotaro Ochi, Yasuhito Nannya, Masakatsu Hishizawa, Daichi Inoue, Ruud Delwel, et al. Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs. British Journal of Haematology. 2024
Koutarou Nishimura, Wataru Saika, Daichi Inoue. Minor introns impact on hematopoietic malignancies. Experimental Hematology. 2024. 132. 104173-104173
Katherine Knorr, Jahan Rahman, Caroline Erickson, Eric Wang, Mara Monetti, Zhuoning Li, Juliana Ortiz-Pacheco, Andrew Jones, Sydney X. Lu, Robert F. Stanley, et al. Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia. Nature Cancer. 2023
Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, Ayana Kon, Yui Koike, Hiromi Tatsumi, June Takeda, Masaki Nomura, Weijia Zang, Manabu Nakayama, et al. SETBP1 is dispensable for normal and malignant hematopoiesis. Leukemia. 2023
Yasutaka Hayashi, Kimihito Cojin Kawabata, Yosuke Tanaka, Yasufumi Uehara, Shigeru Kiryu, Yasunori Ota, Yusuke Yoshioka, Yo Mabuchi, Tatsuki Sugiyama, Keiko Mikami, et al. Impaired Osteoblastic Differentiation of MSCs Suppresses Normal Hematopoiesis in MDS. BLOOD. 2020. 136
Akihide Yoshimi, Kuan-Ting Lin, PhD, Daniel Wiseman, MB, ChB, Andrew M Intlekofer, MD PhD, Bo Wang, Alessandro Pastore, MD, Mohammad Rahman, Stanley Chun-Wei Lee, PhD, et al. Spliceosomal Dysfunction Is a Critical Mediator of IDH2 Mutant Leukemogenesis. BLOOD. 2017. 130. 1. 473
Stanley Chun-Wei Lee, Khrystyna Dilai, Esther A. Obeng, Eunhee Kim, Jean-Baptiste Micol, Akihide Yoshimi, Christophe Willekens, Daichi Inoue, Veronique Saada, Hana Cho, et al. Synthetic Lethal Interactions of MDS-Associated Spliceosomal Gene Mutations Identifies the Basis for Their Mutual Exclusivity. BLOOD. 2016. 128. 22
Reim Nagase, Daichi Inoue, Makoto Saika, Hsin-An Hou, Wen-Chien Chou, Kimihito Kawabata, Hironori Harada, Akinori Kanai, Susumu Goyama, Hiroaki Honda, et al. ANALYSIS OF MDS MICE MODEL INDUCED BY ASXL1 AND RUNX1 MUTANTS. EXPERIMENTAL HEMATOLOGY. 2016. 44. 9. S90-S90
2010 - 2014 The University of Tokyo Graduate School of Medicine
1999 - 2005 Kyoto University Faculty of Medicine Department of Medical Science
Professional career (1):
博士(医学) (東京大学大学院医学研究科)
Work history (11):
2024/04 - 大阪大学大学院医学研究科病理学講座(がん病理学) 教授
2024/04 - 大阪大学大学院生命機能研究科 教授
2021/10 - Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe Professor
2020/07 - ASH (American Society of Hematology) ASH (American Society of Hematology) Global Research Award
2019/11 - 日本白血病研究基金 荻村孝特別研究賞
2019/04 - MDS foundation Young Investigator Award
2017 - Leukemia & Lymphoma Society Special Fellow Award
2015 - 日本学術振興会 日本学術振興会海外特別研究員
2015 - 安田記念医学財団 Fellowship for Research Abroad Award
2015 - かなえ医薬振興財団 Promotion of Medical Science Fellowship Award
2015 - 持田記念医学薬学振興財団 Fellowship for Research Abroad Award
2015 - 6th Japanese Society of Hematology International Symposium Platinum award (Plenary Session)
2015 - 井上科学振興財団 井上研究奨励賞
2014 - 白血病研究基金 白血病研究基金若手特別賞
2014 - Most Outstanding Student Publication Award Most Outstanding Student Publication Award
2013 - 55th American Society of Hematology Annual Meeting Abstract Achievement Award
2013 - 42nd International Society for Experimental Hematology Annual Scientific Meeting Greg Johnson Award
2012 - 日本学術振興会 日本学術振興会特別研究員DC2
2011 - 東京大学医科学研究所 Global COE program Super Research Assistant
2010 - 神戸市立中央市民病院 Best Senior Resident Award 2007-2010
Show all
Association Membership(s) (6):
JAPAN SOCIETY OF CLINICAL ONCOLOGY
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, 日本がん分子標的治療学会
, 米国American Association for Cancer Research
, 米国血液学会